# A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

> clinical trial · VERIFIED · 2026-07-02

Status: RECRUITING · Sponsor: Regeneron Pharmaceuticals · Condition: Paroxysmal Nocturnal Hemoglobinuria

- Company: Regeneron Pharmaceuticals
- Sector: pharma
- Primary source: https://clinicaltrials.gov/study/NCT07154745

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.